Few medical advances have made as large an impact on world health as vaccines. Yet the battle isn’t over. As new infectious diseases emerge, as old ones grow resistant, and as our understanding of human immune response increases, researchers are developing novel vaccines, creative delivery tools, and innovative approaches. Stephene Rose of MPI Research explains why the preclinical realm is especially important to identifying and advancing the most promising candidates that could save innumerable lives.
https://international-pharma.com/wp-content/uploads/2014/07/Ready-for-Battle.pdf